Lauren Sabella

Directeur des opérations chez MANNKIND CORPORATION

Fortune : 2 M $ au 31/05/2024

63 ans

Health Technology

Consumer Services

Postes actifs de Lauren Sabella

Sociétés	Poste	Début	Fin
MANNKIND CORPORATION	Directeur des opérations	27/03/2023	-

Sociétés	Poste	Début	Fin
ACORDA THERAPEUTICS, INC.	Directeur des opérations	09/09/2021	30/09/2022
ACORDA THERAPEUTICS, INC.	Corporate Officer/Principal	25/01/2010	09/09/2021
Tugboat Consulting Group	Fondateur	01/01/2009	01/02/2010
Tugboat Consulting Group	Corporate Officer/Principal	01/01/2009	01/02/2010
Altus Pharmaceuticals, Inc. Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.	Corporate Officer/Principal	01/05/2006	30/09/2008
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Sales & Marketing	01/10/2002	01/04/2006

Hofstra University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	3
Chief Operating Officer	2
Undergraduate Degree	1

Sectorielle

Health Technology	5
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
ACORDA THERAPEUTICS, INC.	Health Technology
MANNKIND CORPORATION	Health Technology

Entreprise privées	3
Altus Pharmaceuticals, Inc. Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.	Health Technology
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology
Tugboat Consulting Group